跳至主要内容
临床试验/EUCTR2014-003007-29-BE
EUCTR2014-003007-29-BE进行中(未招募)1 期

The Polysaccharide Antibody Response Study: Typhim Vi response and allohemagglutinins versus Pneumo 23 vaccine response in the diagnosis of Specific Polysaccharide Antibody Deficiency. - PAR-study

niversity Hospitals Leuven, department of pediatrics0 个研究点开始时间: 2015年7月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subjects, in whom humoral immunity is evaluated, will be included in cohort 1 when the below-mentioned criteria are fulfilled.
  • Assessment of polysaccharide antibody response is indicated for the clinical care of the patient
  • Age between 18 months and 55 years
  • Informed consent given
  • Healthy volunteers, recruited at the travel clinic and by advertising, will be included in cohort 2 when the below-mentioned criteria are fulfilled.
  • Age between 18 months and 55 years
  • Informed consent given
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 120
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Age >55 years
  • Age <18 months
  • History of serious adverse reaction to a vaccine
  • Vaccination with Typhim or Pneumovax 23 in 5 years prior to the study
  • Pregnancy

研究者

发起方
niversity Hospitals Leuven, department of pediatrics

相似试验